Bolt Biotherapeutics, Inc. (BOLT) Operating income 2020–2025
Bolt Biotherapeutics, Inc. (BOLT) annual operating income history from SEC filings — each fiscal year as reported.
-$36.1MFY2025 · since FY2020: -$49.2M → -$36.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$36.1M | +50.6% |
| FY2024 | -$73.0M | +4.1% |
| FY2023 | -$76.2M | +15.6% |
| FY2022 | -$90.3M | +2.7% |
| FY2021 | -$92.8M | -88.7% |
| FY2020 | -$49.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BOLT financial trends
BOLT RevenueBOLT Net incomeBOLT Net marginBOLT Gross profitBOLT Gross marginBOLT Operating marginBOLT Operating cash flowBOLT Free cash flowBOLT Capital expendituresBOLT Return on equityBOLT Stock buybacksBOLT Dividends paidBOLT Total assetsBOLT Total liabilitiesBOLT Shareholders’ equityBOLT overview →